SAN DIEGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics ... concluded that using OGM early in the development of the gene therapy could enable researchers to reduce the number of ddPCR ...

for cell and gene therapy and cancer research, including scientific workshops and poster presentations from Bionano and researchers from across the genomics landscape. AMP’s annual meeting ...

SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that the American Society of Hematology (ASH) Annual Meeting and Exposition 2024 will feature a ...

Erik Holmlin, president and chief executive officer of Bionano, commented ... like blood cancer are insufficient to reliably guide therapy selection and patient management, due to their ...

across cell and gene therapy research, development and manufacturing applications SAN DIEGO, June 13, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its ...

president and chief executive officer of Bionano. “The depth, breadth and scale of studies presented on the use of OGM for hematological malignancy research and cell & gene therapy underscore ...

and Dr. Alicia Bertolotti from Bionano presenting on the utility of optical genome mapping (OGM) across cell and gene therapy research, development and manufacturing applications Two scientific ...

for analysis of CRISPR/Cas edited cells for use in CAR-T therapy SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that the American Society of ...